Skip to main content
Clinical Trials/ACTRN12612000994886
ACTRN12612000994886
Completed
Phase 4

In children under five with WHO defined non-severe pneumonia, is three days of oral cotrimoxazole have the same efficacy than five days of oral cotrimoxazole in reducing fast breathing?

The University of Colorado at Denver and The Children’s Hospital0 sites2,000 target enrollmentSeptember 17, 2012

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
on-severe Pneumonia
Sponsor
The University of Colorado at Denver and The Children’s Hospital
Enrollment
2000
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 17, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
The University of Colorado at Denver and The Children’s Hospital

Eligibility Criteria

Inclusion Criteria

  • The inclusion criteria were: children aged 2\-59 months with WHO defined non\-severe pneumonia

Exclusion Criteria

  • \- children with WHO defined severe or very severe pneumonia or any other severe disease
  • \- children with a history of an allergic reaction to cotrimoxazole or three or more episodes of wheeze or current diagnosis of acute asthma
  • \- those who had been enrolled earlier in the study; required antibiotics for any other condition; had been hospitalized in the previous 2 weeks or who had severe malnutrition.

Outcomes

Primary Outcomes

Not specified

Similar Trials